Odyssey Therapeutics, Inc.
Statements
Balance Sheet
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 24 | Q4 24 | Q1 26 | Q2 26 |
|---|---|---|---|---|
| – | -10.9% | +16.0% | +111.2% | |
| – | -15.2% | +36.6% | +73.7% | |
| – | +50.0% | -39.6% | +129.7% | |
| – | – | – | +76.7% | |
| – | -6.4% | +5.4% | +0.2% | |
| – | -18.1% | -71.9% | -46.3% | |
| – | +1.6% | +29.8% | -91.7% | |
| – | +13.2% | -21.8% | +27.4% | |
| – | – | – | +1.7% | |
| – | +18.7% | +30.1% | -6.7% | |
| – | – | – | – | |
| – | – | – | – | |
| – | +0.0% | +0.0% | -35.8% |
Data as of: October 8, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.